Psychedelics Investing Compass Pathways to Participate in Stifel 2025 Healthcare Conference 05 November
Psychedelics Investing Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months 04 November
Psychedelics Investing NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression 30 October
